{
    "2019-03-25": [
        [
            {
                "time": "",
                "original_text": "华大基因：股东华大投资累计减持3%，完成减持计划 减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "股东",
                        "华大投资",
                        "减持",
                        "3%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:科创板大幕徐徐拉开,医药股主线机会凸显",
                "features": {
                    "keywords": [
                        "医药生物",
                        "科创板",
                        "医药股",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}